Nivolumab plus low-dose ipilimumab in hypermutated HER2-negative metastatic breast cancer: a phase II trial (NIMBUS)
- Romualdo Barroso-Sousa
- Jorge Gomez Tejeda Zanudo
- Tianyu Li
- Sangeetha M. Reddy
- Leisha A. Emens
- Thomas M. Kuntz
- Carolina Alves Costa Silva
- Saud H. AlDubayan
- Hoyin Chu
- Beth Overmoyer
- Paulina Lange
- Molly K. DiLullo
- Meagan Montesion
- Julie Kasparian
- Melissa E. Hughes
- Victoria Attaya
- Ameer Basta
- Nancy U. Lin
- Nabihah Tayob
- Rinath Jeselsohn
- Elizabeth A. Mittendorf
- Sara M. Tolaney
2025-05-13